World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
113
Citations
59543
World Ranking
424
National Ranking
260

Overview

Jeffrey A. Ledbetter is affiliated with the University of Washington in the United States. Their academic profile reflects an early stage or a limited public research footprint as there is no record of published papers, co-authors, or frequent publication venues associated with their name.

Details about the main fields of study, subfields, and specific research topics explored by Ledbetter are not available, indicating that either this information is currently unreported or their work has yet to be widely documented in accessible academic sources.

There is no information on awarded honors or distinctions, nor any known book publications under their authorship. This might suggest a focus primarily on research activities that have not yet culminated in these forms of recognition or output, or incomplete data coverage at this time.

The absence of records relating to recent scholarly papers means that specific contributions, including titles, publication years, and venues, cannot be detailed. Similarly, there is no information on collaborative research partners or frequent venues that might contextualize their academic network or preferred outlets for dissemination.

As Jeffrey A. Ledbetter is currently active and listed as not deceased, their research career may still be in development, or their work may be situated in less publicly visible academic channels. The University of Washington affiliation indicates a connection to a major research institution, which potentially offers diverse opportunities for interdisciplinary engagement and future scholarly output.

Best Publications

  • Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens.

    Jeffrey A. Ledbetter;Leonard A. Herzenberg

  • CTLA-4 is a second receptor for the B cell activation antigen B7.

    Peter S. Linsley;William Brady;Mark Urnes;Laura S. Grosmaire

  • Chimeric antibody with specificity to human b cell surface antigen

    Randy R. Robinson;Alvin Y. Liu;Jeffrey A. Ledbetter

  • The role of the CD28 receptor during T cell responses to antigen.

    Peter S. Linsley;Jeffrey A. Ledbetter

  • Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

    Peter S. Linsley;William Brady;Laura Grosmaire;Alejandro Aruffo

  • Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

    Lieping Chen;Stephanie Ashe;William A. Brady;Ingegerd Hellström

  • Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors

    Peter S. Linsley;JoAnne L. Greene;William Brady;Jürgen Bajorath

  • A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells

    Randolph J. Noelle;Meenakshi Roy;David M. Shepherd;Ivan Stamenkovic

  • Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway

    Tullia Lindstein;Carl H. June;Jeffrey A. Ledbetter;Gregory Stella

  • Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

    Ignacio Melero;Walter W. Shuford;Stephanie Ashe Newby;Alejandro Aruffo

  • Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

    Peter S. Linsley;Philip M. Wallace;Jennifer Johnson;Marylou G. Gibson

  • T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1

    Peter S. Linsley;Edward A. Clark;Jeffrey A. Ledbetter

  • The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

    Alejandro Aruffo;Alejandro Aruffo;Mary Farrington;Diane Hollenbaugh;Xu Li

  • The HE4 (WFDC2) Protein Is a Biomarker for Ovarian Carcinoma

    Ingegerd Hellström;John Raycraft;Martha Hayden-Ledbetter;Jeffrey A Ledbetter

  • 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.

    Walter W. Shuford;Kerry Klussman;Douglas D. Tritchler;Deryk T. Loo

  • CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines

    Craig B. Thompson;Tullia Lindsten;Jeffrey A. Ledbetter;Steven L. Kunkel

  • Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.

    Peter S. Linsley;JoAnne L. Greene;Patrick Tan;Jeff Bradshaw

  • Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies

    Daming Shan;Jeffrey A. Ledbetter;Oliver W. Press

  • How B and T cells talk to each other

    Edward A. Clark;Jeffrey A. Ledbetter

  • Role of the CD28 receptor in T-cell activation.

    Carl H June;Jeffrey A Ledbetter;Peter S Linsley;Craig B Thompson

  • The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.

    D. Hollenbaugh;L.S. Grosmaire;C.D. Kullas;N.J. Chalupny

Frequent Co-Authors

Peter S. Linsley
Peter S. Linsley Benaroya Research Institute
Alejandro Aruffo
Alejandro Aruffo Syngenta (United States)
Gary L. Schieven
Gary L. Schieven Genesis Biotechnology Group
Edward A. Clark
Edward A. Clark University of Washington
Carl H. June
Carl H. June University of Pennsylvania
Diane Hollenbaugh
Diane Hollenbaugh Bonum Therapeutics
Randolph J. Noelle
Randolph J. Noelle Dartmouth College
Peter S. Rabinovitch
Peter S. Rabinovitch University of Washington
Fatih M. Uckun
Fatih M. Uckun University of Southern California
Craig B. Thompson
Craig B. Thompson Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open doors to diverse fields beyond traditional laboratory roles. Many students consider related healthcare careers that blend science and technology, such as medical coding. For an overview of potential earnings, check out this guide on medical.coder salary.

If you’re interested in combining analytical skills with healthcare, the medical billing and coding job outlook shows strong demand and growth opportunities in the industry, making it a reliable pathway for science graduates seeking stable employment.

For those wanting flexible study options, there are many health information management online programs that blend biology, informatics, and business. These degrees can lead to roles in healthcare administration, data analytics, and beyond.

Another increasingly popular pathway is nutrition science. Graduates interested in advanced study and credentialing can find affordable online nutrition masters programs to further specialize and expand career options in wellness, research, and public health.

Best Scientists Citing Jeffrey A. Ledbetter

Trending Scientists